celecoxib has been researched along with l 743,872 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cushion, MT; DiDone, L; Fothergill, AW; Green, J; Halterman, JP; Koselny, K; Krysan, DJ; Patterson, TF; Rappelye, C; Wellington, M; Wiederhold, NP | 1 |
1 other study(ies) available for celecoxib and l 743,872
Article | Year |
---|---|
The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis.
Topics: Animals; Antifungal Agents; Candida; Caspofungin; Celecoxib; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fluconazole; Gene Expression Regulation, Fungal; Lipopeptides; Male; Mice, Inbred Strains; Microbial Sensitivity Tests; Pneumocystis; Pyrazoles; Saccharomyces cerevisiae; Sulfonamides | 2016 |